Company Information
USD
12.9
- (-4.3%)
NASDAQ:NVAX, NOVAVAX, INC.
Industry: Biotechnology
End of Day: 15 May 2024 GMT-4
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
Address
700 Quince Orchard Road
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Gregg H. Alton, J.D.
Director
Ms. Margaret G. McGlynn
Director
Mr. Richard J. Rodgers
Director
Dr. James F. Young, PhD
Chairman of the Board/Director
Mr. David M. Mott
Director
Mr. Mark J. Casey
Chief Legal Officer/Secretary
Dr. Richard H. Douglas, PhD
Director
Mr. John J. Trizzino
COO/President
Ms. Rachel K. King
Director
Mr. John C. Jacobs
CEO/Director/President
Mr. James P. Kelly
CFO/Chief Accounting Officer/Executive VP/Treasurer
Dr. Filip Dubovsky, M.D.
President, Divisional
Ms. Elaine O'Hara
Chief Strategy Officer/Executive VP
Ownership
Institution Holdings
State Street Corporation
16,775,875 (11.987%)
SSGA Funds Management Inc
15,324,642 (10.950%)
Vanguard Group Inc
14,560,061 (10.404%)
BlackRock Inc
8,436,179 (6.028%)
Shah Capital Management
7,780,756 (5.560%)
SK Discovery Co Ltd
6,500,000 (5.472%)
Morgan Stanley - Brokerage Accounts
7,241,455 (5.174%)
BlackRock Fund Advisors
4,385,866 (3.134%)
Vanguard Investments Australia Ltd
3,836,964 (2.742%)
Geode Capital Management, LLC
2,297,507 (1.642%)
Funds Holdings
SPDR® S&P Biotech ETF
15,135,620 (10.815%)
Vanguard Small Cap Index
2,881,172 (2.059%)
iShares Russell 2000 ETF
2,328,231 (1.664%)
Vanguard Institutional Extnd Mkt Idx Tr
1,828,449 (1.306%)
Vanguard Small Cap Growth Index Fund
1,605,136 (1.147%)
Vanguard Strategic Equity Fund
1,542,664 (1.102%)
Vanguard Explorer Fund
972,371 (0.695%)
Fidelity Small Cap Index Fund
949,757 (0.679%)
iShares Biotechnology ETF
838,973 (0.599%)
iShares Russell 2000 Growth ETF
688,425 (0.492%)
Make Smart Investment Choices